Borbujo J, García-Villalón A L, Valle J, Gómez B, Diéquez G
Servicio de Dermatología, Hospital La Paz, Madrid, Spain.
J Pharmacol Exp Ther. 1989 Apr;249(1):284-7.
Experiments were performed to characterize the postjunctional alpha adrenoceptors that mediate adrenergic constriction in human skin arteries. Abdominal s.c. arteries were obtained from patients who died 3 to 12 hr before, and vascular segments 2 mm in length and 600 to 1050 microns in external diameter were prepared for isometric tension recording. On application of norepinephrine, phenylephrine (alpha-1 adrenergic agonist) or clonidine (alpha-2 adrenergic agonist) the arteries contracted in a dose-dependent manner and, in terms of the mean EC50 values, the order of potencies was clonidine greater than norepinephrine greater than phenylephrine. With regard to their ability to induce maximal contraction, the order was norepinephrine = phenylephrine greater than clonidine. In the presence of phentolamine (nonspecific alpha adrenergic antagonist) or yohimbine (selective alpha-2 adrenergic antagonist) the control curve for norepinephrine was displaced to the right in a parallel way. Prazosin (selective alpha-1 adrenergic antagonist) depressed both the slope and maximal response of the control curve for norepinephrine but the shift was not significant. Prazosin and yohimbine produced a parallel rightward shift in the control curve for phenylephrine and clonidine, respectively. These results suggest that skin arteries of humans have a mixed population of postjunctional alpha-1 and alpha-2 adrenoceptors and that alpha-2 adrenoceptors are more prominent. They also suggest that the alpha-2 adrenergic component of the response to norepinephrine is a low-maximum effect compared to the alpha-1 adrenergic component. This could be of significance in regulating skin blood flow and thermoregulatory function.
进行实验以表征介导人皮肤动脉肾上腺素能收缩的节后α肾上腺素能受体。从死亡3至12小时前的患者获取腹部皮下动脉,并制备长度为2mm、外径为600至1050微米的血管段用于等长张力记录。应用去甲肾上腺素、苯肾上腺素(α-1肾上腺素能激动剂)或可乐定(α-2肾上腺素能激动剂)后,动脉呈剂量依赖性收缩,就平均EC50值而言,效力顺序为可乐定>去甲肾上腺素>苯肾上腺素。关于它们诱导最大收缩的能力,顺序为去甲肾上腺素 = 苯肾上腺素>可乐定。在酚妥拉明(非特异性α肾上腺素能拮抗剂)或育亨宾(选择性α-2肾上腺素能拮抗剂)存在的情况下,去甲肾上腺素的对照曲线以平行方式向右移位。哌唑嗪(选择性α-1肾上腺素能拮抗剂)降低了去甲肾上腺素对照曲线的斜率和最大反应,但移位不显著。哌唑嗪和育亨宾分别使苯肾上腺素和可乐定的对照曲线向右平行移位。这些结果表明,人类皮肤动脉具有节后α-1和α-2肾上腺素能受体的混合群体,且α-2肾上腺素能受体更为突出。它们还表明,与α-1肾上腺素能成分相比,对去甲肾上腺素反应的α-2肾上腺素能成分是一种低最大效应。这在调节皮肤血流和体温调节功能方面可能具有重要意义。